Denver PWM’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359K Sell
6,400
-500
-7% -$29.1K 0.12% 67
2025
Q4
$319K Hold
6,900
0.11% 63
2025
Q3
$319K Hold
6,900
0.1% 65
2025
Q2
$319K Buy
6,900
+750
+12% +$36.8K 0.1% 65
2025
Q1
$375K Buy
+6,150
New +$358K 0.14% 49

Other funds holding BMY

Denver PWM's BMY Position: Q1 2026 in Review

Denver PWM reduced its Bristol-Myers Squibb (BMY) stake by 7.2% in Q1 2026, selling an estimated $29.1K and leaving 6,400 shares worth $359K. The position accounts for 0.12% of the portfolio, ranked #67.

Denver PWM first reported a position in BMY in Q1 2025 and has held it in 5 quarters since. The position peaked at $375K in Q1 2025. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Denver PWM held 6,400 shares of Bristol-Myers Squibb worth $359K as of Q1 2026.
  • Denver PWM sold 500 Bristol-Myers Squibb shares in Q1 2026, an estimated $29.1K.
  • Bristol-Myers Squibb made up 0.12% of Denver PWM's portfolio in Q1 2026, its #67 holding.
  • Denver PWM first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 5 quarters since.
  • Denver PWM's Bristol-Myers Squibb position peaked at $375K in Q1 2025.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Denver PWM's 13F filing for Q1 2026, filed 13 May 2026.